Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Nanning
Clinical trial register · China

Clinical Trials in Nanning, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 3 Shenzhen 2 Wuhan 2 Jinan 2 Chengdu 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
First Affiliated Hospital of Guangxi Medical University23 Merck Sharp & Dohme LLC22 Sun Yat-sen University18 BeOne Medicines14 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.13 Pfizer11 Bristol-Myers Squibb11 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.10 Guangxi Medical University9 AstraZeneca8 Nanjing Leads Biolabs Co.,Ltd7 Hoffmann-La Roche6 CorrectSequence Therapeutics Co., Ltd5 AbbVie5 Sanofi5 Novartis Pharmaceuticals5 Allist Pharmaceuticals, Inc.4 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.4 Sinovac Biotech Co., Ltd4 Tongji Hospital4 Daiichi Sankyo4 MediLink Therapeutics (Suzhou) Co., Ltd.3 RemeGen Co., Ltd.3 Celgene3 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.3 GlaxoSmithKline3 Institute of Hematology & Blood Diseases Hospital, China3 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School3 Takeda3 Hutchmed3 Bioray Laboratories3 Eli Lilly and Company3 Shanghai Henlius Biotech3 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University3 Hansoh BioMedical R&D Company3 DualityBio Inc.3 Abbisko Therapeutics Co, Ltd3 Boehringer Ingelheim3 Second Xiangya Hospital of Central South University2 Klus Pharma Inc.2 Peking University People's Hospital2 TJ Biopharma Co., Ltd.2 Yousheng Xiao2 Biogen2 Cancer Hospital of Guangxi Medical University2 Shanghai Jiaolian Drug Research and Development Co., Ltd2 Sinocelltech Ltd.2 Peking University First Hospital2 Jiangsu HengRui Medicine Co., Ltd.2 Haihe Biopharma Co., Ltd.2 Huashan Hospital2 Hangzhou Sumgen Biotech Co., Ltd.2 BioNTech SE2 Nuvation Bio Inc.2 Amgen2 Guangzhou Lupeng Pharmaceutical Company LTD.2 Ming-Yuan Chen2 Ausper Biopharma Co., Ltd.2 Seagen, a wholly owned subsidiary of Pfizer2 Dizal Pharmaceuticals2 Chinese Academy of Sciences2 Shanghai Bovax Biotechnology Co., Ltd.2 Genfleet Therapeutics (Shanghai) Inc.2 InSilico Medicine Hong Kong Limited2 Summit Therapeutics2 Institute of Medical Biology, Chinese Academy of Medical Sciences2 Haisco Pharmaceutical Group Co., Ltd.2 Suzhou Abogen Biosciences Co., Ltd.2 TCRx Therapeutics Co.Ltd2 West China Second University Hospital2 Multitude Therapeutics Inc.2 Janssen Research & Development, LLC2 Beijing InnoCare Pharma Tech Co., Ltd.2 Children's Hospital of Soochow University2 Peking Union Medical College Hospital2 Alexion Pharmaceuticals, Inc.2 Wigen Biomedicine Technology (Shanghai) Co., Ltd.2 Guangdong Association of Clinical Trials2 Eye & ENT Hospital of Fudan University2 Beijing Tiantan Hospital2 BeiGene2 Second Affiliated Hospital of Guangxi Medical University2 Innovent Biologics (Suzhou) Co. Ltd.2 Ascentage Pharma Group Inc.2 Bisirna Therapeutics (Suzhou) Co., Ltd.1 Fortvita Biologics (USA)Inc.1 Shanghai Jiao Tong University School of Medicine1 Chinese SLE Treatment And Research Group1 Changhai Hospital1 ScinnoHub Pharmaceutical Co., Ltd.1 Suzhou BlueHorse Therapeutics Co., Ltd.1 Beijing QL Biopharmaceutical Co.,Ltd1 argenx1 Sixth Affiliated Hospital, Sun Yat-sen University1 Fujian Cancer Hospital1 JHM BioPharma (Tonghua) Co. , Ltd.1 Bayer1 Hope Medicine (Nanjing) Co., Ltd1 Shanghai BDgene Co., Ltd.1 Genentech, Inc.1 The Affiliated Hospital Of Guizhou Medical University1 Rongrong Liu1 Gilead Sciences1 Ranok Therapeutics (Hangzhou) Co., Ltd.1 DK Medical Technology (Suzhou) Co., Ltd.1 Fudan University1 Lepu Biopharma Co., Ltd.1 Cytokinetics1 Heronova Pharmaceuticals1 Jacobio Pharmaceuticals Co., Ltd.1 Xiang Gao1 Medtronic1 Hangzhou Gensciences Biopharmaceutical Co., Ltd.1 Chinese Academy of Medical Sciences, Fuwai Hospital1 Anthos Therapeutics, Inc.1 Inventiva Pharma1 Dermavon Holdings Limited1 Chunyan Ma1 Chinese PLA General Hospital1 Eisai Co., Ltd.1 Mabwell (Shanghai) Bioscience Co., Ltd.1 Shanghai Pulmonary Hospital, Shanghai, China1 Ningbo Newbay Technology Development Co., Ltd1 Bio-Thera Solutions1 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.1 Peking Union Medical College1 Suzhou HepaThera Biotech Co., Ltd.1 Suzhou Suncadia Biopharmaceuticals Co., Ltd.1 Advenchen Laboratories, LLC1 Grit Biotechnology1 Sichuan Baili Pharmaceutical Co., Ltd.1 Zhongshan People's Hospital, Guangdong, China1 Nanjing RegeneCore Biotech Co., Ltd.1 Jiangsu BioJeTay Biotechnology Co., Ltd.1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 Loxo Oncology, Inc.1 Mirati Therapeutics Inc.1 Shenzhen Fosun Kairos Biotechnology Co., Ltd.1 Kai Hu1 Qiu Ye1 OncoC4, Inc.1 Genmab1 Huahui Health1 CStone Pharmaceuticals1 Jiangsu Jingze Biopharmaceutical Co., Ltd.1 Herui Yao1 Shanghai Allink Biotherapeutics Co., Ltd.1 EMD Serono Research & Development Institute, Inc.1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1 Nanjing Medical University1 Yanbing Yu1 Beijing Anzhen Hospital1 Suzhou Genhouse Bio Co., Ltd.1 The Affiliated Hospital of the Chinese Academy of Military Medical Sciences1 Novo Nordisk A/S1 Huazhong University of Science and Technology1 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 Lyvgen Biopharma Holdings Limited1 Binhui Biopharmaceutical Co., Ltd.1 Guangzhou Virotech Pharmaceutical Co., Ltd.1 Affiliated Hospital of Changchun University of Chinese Medicine1 Xuanwu Hospital, Beijing1 Shenzhen Hemogen1 Cascade Pharmaceuticals, Inc1 OBI Pharma, Inc1 Kind Pharmaceuticals LLC1 Shanghai Pharmaceuticals Holding Co., Ltd1 Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1 Excyte Biopharma Ltd1 Ferring Pharmaceuticals1 Second Affiliated Hospital, Zhejiang University, School of Medicine1 Shenzhen NewDEL Biotech, Co., Ltd1 ImmuneOnco Biopharmaceuticals (Shanghai) Inc.1 Harbin Medical University1 Forward Pharmaceuticals Co., Ltd.1 Oupushifang Pharmaceutical Technology Co., Ltd.1 3D Medicines (Sichuan) Co., Ltd.1 JIANGSU SHENMING Medical Technology CO., Ltd1 Tianjin Medical University Cancer Institute and Hospital1 Otsuka Pharmaceutical Development & Commercialization, Inc.1 Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd1 Sir Run Run Shaw Hospital1 Sun Yat-Sen University Cancer Center1 Guangdong Provincial People's Hospital1 Shanghai RAAS Blood Products Co., Ltd.1 Shanghai Zhongshan Hospital1 Astellas Pharma Global Development, Inc.1 JW Medical Systems Ltd1 Clear sponsor filter
Target enrolment
to

Trials with a site in Nanning

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Beijing, Xiamen, Guangzhou, Shenzhen, Liuzhou, Nanning, Wuhan, Changsha
2022-03-15
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/nanning

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Nanning that also match the filters currently applied.

How many clinical trials are recruiting in Nanning?

0 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nanning), 1 studies
PhaseStudiesRecruitingShare
Phase 310100%

Most active sponsors

Lead sponsors with the most studies (Nanning)
Lead sponsorStudiesRecruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.